Radiodermatitis

27 registered clinical trials studyying Radiodermatitis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis NCT07029178	Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University	Phase 2
Unknown	Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy. NCT05886673	Antonio J. Conde Moreno	N/A
Unknown	Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiother NCT05535452	Instituto Nacional de Cancer, Brazil	N/A
Withdrawn	Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis. NCT04692389	Welcare Industries SpA	N/A
Unknown	Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold. NCT04617730	Jules Bordet Institute	Phase 1 / Phase 2
Completed	Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis. NCT04067310	Instituto Nacional de Cancer, Brazil	N/A
Completed	Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis. NCT04483856	Relife Italia S.r.l.	N/A
Withdrawn	A Novel Skin Barrier Protectant for Acute Radiodermatitis NCT04593914	Jessa Hospital	N/A
Completed	Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Ra NCT03924011	Hasselt University	N/A
Completed	Preventive Effect of Boron-based Gel on Radiation Dermatitis NCT04239560	Tabriz University of Medical Sciences	Phase 3
Completed	Photobiomodulation for Breast Cancer Radiodermatitis NCT04059809	AC Camargo Cancer Center	Phase 2 / Phase 3
Completed	Thermal Imaging to Evaluate Skin Toxicity From Radiotherapy NCT04013711	Sunnybrook Health Sciences Centre	N/A
Unknown	Evaluation of Fenofibrate on Radiation-induced Skin Injury NCT03557983	Second Affiliated Hospital of Soochow University	N/A
Completed	Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid® NCT03255980	Helsinn Healthcare SA	N/A
Completed	Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients NCT02922244	Chulabhorn Cancer Center	N/A
Unknown	Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for NCT02729324	Yun-fei Xia	Phase 2
Completed	Patient Reported Outcomes Using Mepitel Film During Radiotherapy NCT06133218	Odense University Hospital	N/A
Unknown	Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis NCT02251392	University of Brasilia	Phase 3
Terminated	Topical Use of Difinsa53™ to Prevent Radiation Dermatitis NCT02534129	ProTechSure Scientific, Inc.	Phase 1 / Phase 2
Completed	Management Radiodermatitis in Patients With Breast or Head and Neck Cancer NCT02247830	University of Brasilia	Phase 3
Unknown	Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients NCT02289365	Joben Bio-Medical Co., Ltd.	Phase 2
Completed	Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis NCT02249884	University of Brasilia	Phase 2
Completed	Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast Cancer NCT01925651	AC Camargo Cancer Center	N/A
Withdrawn	Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy NCT01544504	ProCertus BioPharm, Inc	Phase 1 / Phase 2
Terminated	Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiothe NCT01367990	ProCertus BioPharm, Inc	Phase 1
Terminated	Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients NCT01263366	ProCertus BioPharm, Inc	Phase 1
Unknown	The Role of Calcipotriol as Radioprotector of Skin NCT00445250	Rabin Medical Center	Phase 2